WHO “strongly recommends early ttmraeent with the antiviral drugs, oseltamivir or zanamivir, for patients who meet ttmraeent criteria, even in the absence of a positive laboratory test confirming H1N1 infection.” That means Tamiflu, the highly dangerous drug whose major shareholder includes former Pentagon head Don Rumsfeld. And it means GlaxoSmithKline, maker of the reportedly equally dangerous rival Relenza drug. The drugs produce precisely the symptoms of severe lung complications found in flu and in some cases have reportedly caused death.